Sort by
Refine Your Search
-
temporal and spatial controlled drug release systems through stimuli-responsive materials. These tasks are part of a larger Empa's initiative, called Wound Booster , involving several PhD students working
-
part of a large international research center in collaboration with Denmark Technical University and University of Copenhagen and bridges our activities in the fields of nanocelluloses, proteins and
-
. Empa is a research institution of the ETH Domain. Our Laboratory for High Performance Ceramics in Dübendorf, near Zürich, is looking for a PhD Student within a project funded by the Swiss National
-
functionality. Publish in peer-reviewed high-impact factor journals and present at international conferences. Your profile MSc in Materials Science, Polymer Chemistry, Chemical Engineering or related disciplines
-
. Demonstrated aptitude for scientific creativity and non-conventional thinking. Fluent in written and oral English. Self-motivated, critical-thinking, open-minded and communicative, with a strong interest to work
-
characterization is highly appreciated. We are looking for committed and creative individuals able to work in a team. The candidate will work in a top-level research environment with state-of-the-art laboratory
-
how perishable biological products react inside cold chain unit operations and to pinpoint why some products decay faster. For that purpose, we develop digital twins of the cargo, based on measured air
-
. Empa is a research institution of the ETH Domain. The Laboratory of High Performance Ceramics is offering a PhD position focused on the development of new catalytic materials for CO2 conversion
-
. Empa is a research institution of the ETH Domain. Your tasks Your tasks will focus on the design and operation of experiments to investigate the failure mechanisms in wooden structures. This will require
-
of this project, you will work with a team of scientists with backgrounds in chemistry, cell biology and microbiology as well as with clinical partners on the development of engineered corneal transplant to treat